Pros | ![]() 3Y returns in the top 25% of the category. | - | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 4 Years | 1 Years | ||
Fund Size | 166 Cr | 3496 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹500 Lumpsum ₹500 | ||
Expense Ratio | 0.51% | 0.42% | ||
Exit Load | 0% | 1% | ||
Benchmark Index | MSCI Ind Dom & Wld HealthC 45 NR INR | Nifty India Defence TR INR |
No of Holdings | 48 | 20 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.45%) Max Healthcare Institute Ltd Ordinary Shares (6.77%) Cipla Ltd (6.14%) Divi's Laboratories Ltd (5.51%) Apollo Hospitals Enterprise Ltd (5.28%) | Hindustan Aeronautics Ltd Ordinary Shares (21.12%) Bharat Electronics Ltd (21.06%) Solar Industries India Ltd (14.62%) Mazagon Dock Shipbuilders Ltd (8.88%) Cochin Shipyard Ltd (6.32%) | ||
No of Sectors | 1 | 4 | ||
Top 3 Sectors | Health (100%) | Industrial (79.33%) Basic Materials (15.43%) Tech (4.15%) | ||
Equity % | 99.77% | 100.02% | ||
Debt % | - | - | ||
P/E | 32.98 | 49.8 | ||
P/B | 5.89 | 10.78 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.01% | -5.87% | ||
3-Month Return | 5.37% | -12.08% | ||
6-Month Return | 5.44% | 41.14% | ||
1-Year Return | 0.82% | 6.66% | ||
3-Year Return | 19.4% | - | ||
5-Year Return | - | - |
Sharpe | 0.95 | - | ||
Alpha | - | - | ||
Beta | - | - | ||
Standard Deviation | 12.39 | - | ||
Information Ratio | - | - |
Description | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Motilal Oswal Nifty India Defence Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Bhavesh Jain,Amit Vora | Swapnil Mayekar,Rakesh Shetty,Dishant Mehta |